Novel [D-Arg2]dermorphin(1-4) analogs with mu-opioid receptor antagonist activity. 2002

Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
Tohoku Pharmaceutical University, Sendai, Japan.

Ten Tyr-D-Arg-Phe-betaAla-NH(2) (YRFB) analogs in which specific amino acid side chains are shifted to the N(alpha)-position were synthesized, and the binding to these analogs to the mu receptor and their in vitro biological properties were evaluated. Some analogs in which a N,N-bis(p-hydroxybenzyl)-Gly residue was substituted for Tyr(1) exhibited mu receptor antagonist activities (pA(2)) between 5.3 and 6.1. Of these analogs, [N,N-bis(p-hydroxybenzyl)-Gly(1)]YRFB was found to be the most potent specific antagonist for the mu-opioid receptor.

UI MeSH Term Description Entries
D008297 Male Males
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017450 Receptors, Opioid, mu A class of opioid receptors recognized by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine. Morphine Receptors,Opioid Receptors, mu,Receptors, Morphine,Receptors, mu,Receptors, mu Opioid,mu Receptors,Morphine Receptor,mu Opioid Receptor,mu Receptor,Opioid Receptor, mu,Receptor, Morphine,Receptor, mu,Receptor, mu Opioid,mu Opioid Receptors
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
September 2005, The journal of peptide research : official journal of the American Peptide Society,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
November 1992, The Journal of pharmacology and experimental therapeutics,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
January 2024, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
August 1993, The Journal of pharmacology and experimental therapeutics,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
January 1986, Pharmacology, biochemistry, and behavior,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
January 1990, Peptides,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
April 1984, Biochemical and biophysical research communications,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
August 1985, Biochemical and biophysical research communications,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
November 1985, Chemical & pharmaceutical bulletin,
Akihiro Ambo, and Takanori Terashima, and Yusuke Sasaki
July 2004, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!